David Gallardo Giralt

Name:
David Gallardo Giralt
Sign: David Gallardo Giralt
Position:
Responsable del Grup
Read More

Our group has been investigating the impact of mhAg mismatches on clinical outcome after allogeneic hematopoietic stem cell transplantation from an hLAidentical sibling donor. Currently, we have dNA samples and clinical information from more than 1700 patient/donor pairs ready to analyse the correlation between genotype and clinical outcome.

Spanish

Grup de Recerca Reconegut per la Generalitat de Catalunya

Finançat per: Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (2014 SGR 21)

Durada: des de 2014 fins a 2016

Investigador responsable: David Gallardo

 

Minor Histocompatibility antigens as mediators of immune alloreactivity in human transplantation.

Finançat per: Fundació Marató TV3

Durada: des de 2013 fins a 2015

Investigador responsable: David Gallardo

 

Red de Cáncer. (RD12/0036/0029)

Finançat per: Instituto de Salud Carlos III

Durada: des de 2013 fins a 2015

Investigador responsable: Joan Gil Santano


Papel de los polimorfismos genéticos de CD38 Y CD31 en  la leucemia linfática crónica. 

Finançat per: Fundación Mutua Madrileña

Durada: des de 2011 fins a 2013

Investigador responsable: Josep Mª Roncero

 

Biobanco de aloTPH del GETH. Polimorfismos en antígenos menores de histocompatibilidad y genes moduladores de respuesta inmune como predictores de alorreactividad. (PI11/01690)

Finançat per: Instituto de Salud Carlos III

Durada: des de 2012 fins a 2014

Investigador responsable: David Gallardo

 

 

Are you investigator?

English

If you research if you are interested in helping with any of our research groups, fill out this form. We will contact you as soon as possible. Thank you.

Send us your details

Read More
Read More
Our group has been investigating the impact of mhAg mismatches on clinical outcome after allogeneic hematopoietic stem cell transplantation from an hLAidentical sibling donor. Currently, we have dNA samples and clinical information from more than 1700 patient/donor pairs ready to analyse the correlation between genotype and clinical outcome.
Team envolved in “Red Temática de Investigación Cooperativa en Cáncer (RTICC)” Recognised as a consolidated research group - 2014SGR21 

 

Strategic objectives

English

Grup de Recerca Reconegut per la Generalitat de Catalunya

Finançat per: Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (2014 SGR 21)

Durada: des de 2014 fins a 2016

Investigador responsable: David Gallardo

 

Minor Histocompatibility antigens as mediators of immune alloreactivity in human transplantation.

Finançat per: Fundació Marató TV3

Durada: des de 2013 fins a 2015

Investigador responsable: David Gallardo

 

Red de Cáncer. (RD12/0036/0029)

Finançat per: Instituto de Salud Carlos III

Durada: des de 2013 fins a 2015

Investigador responsable: Joan Gil Santano


Papel de los polimorfismos genéticos de CD38 Y CD31 en  la leucemia linfática crónica. 

Finançat per: Fundación Mutua Madrileña

Durada: des de 2011 fins a 2013

Investigador responsable: Josep Mª Roncero

 

Biobanco de aloTPH del GETH. Polimorfismos en antígenos menores de histocompatibilidad y genes moduladores de respuesta inmune como predictores de alorreactividad. (PI11/01690)

Finançat per: Instituto de Salud Carlos III

Durada: des de 2012 fins a 2014

Investigador responsable: David Gallardo

 

 

Are you investigator?

English

If you research if you are interested in helping with any of our research groups, fill out this form. We will contact you as soon as possible. Thank you.

Send us your details

Read More

Highly variable mutational profile of ASXL1 in myelofibrosis.

Subscribe to David Gallardo Giralt